Search
for
Sort by
Research 481–510 of 824
- 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY
- Iatrogenic Cushing's Syndrome in a Patient With Salt-Wasting Congenital Adrenal Hyperplasia (SWCAH)
- 309 DOES VARIATION IN EITHER AGE AT START OF THERAPY OR DURATION OF THERAPY MAKE CHEMOPREVENTION WITH FINASTERIDE COST-EFFECTIVE?
- Replenishing amino acids in damaged hair
- Hair loss, quality of life impact
- Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer: Results at 3 Years
- Testosterone (T) secreting tumor or insulin resistance? metformin (M) as a diagnostic (Dx) and therapeutic (Rx) trial
- 199 Computer vision AI-based androgenetic alopecia analysis using a novel mobile web app
- 1374 Cell-cell interaction in the hair follicle niche in androgenetic alopecia
- 1391 Cell death functions in hair follicle regeneration
- 1448 Ligand-dependent Wnt signaling attenuates mechanotransduction and protects against wound occlusion-mediated abolishment of hair follicle regeneration
- 1343 Efficacy of asymmetric siRNA targeting androgen receptor for the treatment of androgenetic alopecia
- 1116 Novel androgen receptor degrader for androgenetic alopecia (AGA) application
- 652 Efficacy comparison of photobiomodulation devices in the treatment of androgenetic alopecia
- 1342 Spatial transcriptome profiling reveals TGFβ-2 in hair follicle progenitor cells is a potential driver of androgenetic alopecia
- 1077 Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial
- 1441 Platelet-rich plasma for treatment of androgenetic alopecia, effective or not? A review of the literature
- 1494 Dual effects of HA-iMSC-exosomes in human follicle dermal papilla cells (HFDPC) on androgenic alopecia in vitro model
- 503 Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- 602 Efficacy of autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: A single arm, multi-center, confirmatory clinical study
- 303 The role of rare variants in male-pattern hair loss: Analysis of whole exome sequencing data in the UK Biobank
- 589 Platelet rich plasma combination therapies for treatment of androgenetic alopecia: A systematic review
- 561 Vellus-to-terminal hair follicle reconversion does occur in male pattern balding in a new humanized mouse model of androgenetic alopecia and is promoted by minoxidil and PRP
- 564 Vertex and Occipital Intermediate and Terminal Hair Follicles from Androgenetic Alopecia Patients are Differentially Affected by Testosterone Ex Vivo
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 35372 Skin type and efficacy of laser treatment for androgenic alopecia
- 33244 Increased risk of hyperkalemia in older women taking spironolactone for female pattern hair loss
- 35055 A survey of patient attitudes on topical minoxidil for the treatment of hair loss
- 595 In vitro evaluation of skin distribution and human dermal papilla cells proliferation for minoxidil 5% topical lotion hydrogel